OpenText’s investments in Documentum and Leap may answer drug makers prayers
OpenText properties like iHub, Brava!, BPM, Magellan to play pivotal roles
Not one day after OpenText announced that it was buying Dell EMC’s enterprise content division, the scuttlebutt began…Naysayers, newsmakers and anyone who could tag a byline on a blogpost declared that innovation on Documentum was done, that OpenText acquired the leading ECM platform to profit from recurring license revenues, and that Leap and InfoArchive were too insignificant to be nurtured there.
OpenText CMO Adam Howatson insisted that those fears were unfounded and that instead OpenText may be Documentum’s “saving grace.” Considering that Rohit Ghai, the president of ECD prior to its acquisition, had told CMSWire that “Documentum is done, that no more for functions or features will be added,” Howatson’s message should have sounded like music to Documentum users’ ears.
Except that perhaps they couldn’t hear over all of the noise competitors, and parties with other interests, were, and still are, making.
If you’re a Documentum user and you didn’t get up and dance, that’s OK. We have a progress report and screenshots too.
Documentum through a Life Sciences lens
Documentum has always been a favorite of pharmaceutical companies, so much so that 19 out of top 20 drug makers use its solutions in areas like clinical, regulatory and quality. And while Documentum’s Life Sciences Suite including Electronic Trial Master File, Research & Development, Submission Store & View, and Quality & Manufacturing have been especially well received, Jaleel Shujath, director industry marketing at OpenText, says that they want to make things easier for their customers.
“We’re working very hard to bring in analytics (via OpenText’s iHub) to help with data visualization and reporting,” says Shujath.
The first evidence of this is the Documentum Life Sciences regulatory dashboard:
It leverages iHub’s integration to Documentum to help regulatory managers quickly discern how long it is taking to get approvals.
With the Regional Product dashboard users can see where an approval stands.
Imagine the difference it makes if you can look at a visualization like this rather than rummage through reports while preparing for a meeting or answering a progress request while you are on the road. Never mind how easy it becomes to collaborate.
There’s also a product dashboard showing worldwide approval progress for a drug
as well as a product submission table. These dashboards provide a basis from which predictions might be made, according to Lori McKellar, director solutions marketing at OpenText.
What is the win here, if you are a non-Life Sciences user? It’s a look at the capabilities that are coming your way when iHub is fully integrated with Documentum.
Needless to say, other users in other industries will have dashboards that relate to their work. It’s likely that an API will be open to partners as well.
Simple, streamlined, personalized
OpenText also gave us a peek into Life Sciences Express, a solution based on the OpenText platform, that provides a tailored experience based on the user’s role.
There is also a clear reviewing capability that makes it infinitely easier to review documents and complete tasks.
Work smart, make better decisions
Needless to say, easy, governed access to information and insights represent huge wins, but these examples are just the beginning of the story according to Shujath. OpenText has industry leading products in areas like business process management, artificial intelligence (Magellan), Digital Asset Management and more.
“We can create an end to end story from discovery to commercialization,” says Shujath.
